SINOHEALTH HLDG (02361) Achieves Significant Progress in Commercialization of AI Large Models and AI Agents, Successfully Transforms into AI Tech Service Provider

Stock News2025-12-24

SINOHEALTH HLDG (02361) announced that, as of the date of this announcement, the company has made notable advancements in the commercial application of AI large models and AI agents. Its AI services and products now cover marketing, healthcare, pharmacies, and consumer management scenarios, reaching a comprehensive health industry collaboration network encompassing "medical, pharmaceutical, and patient" sectors.

In marketing, the company has launched the "AI Marketing Lab" and introduced the "Tiangong-1 Commercial AI Agent," providing "+AI" digital intelligence solutions to 182 pharmaceutical companies. These solutions empower enterprises to achieve rapid responses, efficient decision-making, and action in dynamic environments.

In healthcare, leveraging its self-developed "Zhumuniao Medical Large Model," the company has rolled out the "iMDT" intelligent agent for multidisciplinary team consultations on severe diseases. It has served 512 hospitals and assisted over 1,520 clinicians in complex medical diagnoses, significantly improving the decision-making quality of multidisciplinary teams (MDT).

In the pharmacy sector, the company's pharmacy AI agent has been adopted by more than 10,993 pharmacies. Utilizing comprehensive industry data, the company has established a five-matrix AI agent system covering operational insights, products, diseases, members, and staff, along with specialized AI for "individuals, families, diseases, and medication," enhancing store operations.

In health management, the company has built an AI agent matrix targeting "individuals, families, disease types, and medication," precisely serving over 3 million users. It provides personalized health interventions and risk alerts, forming a full-cycle management system that includes prevention, screening, and intervention.

The disclosed business data confirms the company's successful transition from a data technology service provider to an AI-driven tech service provider. SINOHEALTH HLDG will continue refining its "data + model + scenario + ecosystem" capabilities, striving to become the preferred AI service provider in the health industry.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment